Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pacific Edge Limited ( (PFGTF) ) just unveiled an update.
Pacific Edge Limited announced that 1,928,988 options to acquire ordinary shares have lapsed, which represents 0.19% of the total ordinary shares on issue. This lapse occurred because the conditional right to exercise these options expired, leaving the company with 47,839,896 options to acquire ordinary shares still on issue. This development may impact stakeholders by slightly altering the company’s capital structure, but it does not significantly affect the overall number of shares available.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on developing and commercializing diagnostic tests for the early detection and management of cancer. The company is known for its innovative solutions that aim to improve patient outcomes and reduce healthcare costs.
Find detailed analytics on PFGTF stock on TipRanks’ Stock Analysis page.